Does Methotrexate Affect Thyroid Function?
Methotrexate can decrease total thyroxine (TT4) levels in patients with rheumatoid arthritis, though thyroid monitoring is not routinely recommended in standard guidelines for MTX use in dermatologic or rheumatologic conditions. 1
Evidence for Thyroid Effects
The most recent research demonstrates a specific thyroid impact:
A 2023 cross-sectional study of 281 RA patients found that methotrexate use was significantly associated with decreased total thyroxine (TT4) levels (TT4 < 78.38 nmol/L, OR = 0.067,95% CI: 0.008-0.588, P = 0.015). 1
This study suggests that MTX may affect thyroid function while treating the underlying disease, potentially contributing to secondary thyroid dysfunction in RA patients. 1
Clinical Context and Guideline Recommendations
Major dermatology and rheumatology guidelines do not include routine thyroid function monitoring in their MTX protocols, which is notable given the research findings:
The 2020 American Academy of Dermatology/National Psoriasis Foundation guidelines recommend baseline and ongoing monitoring of CBC, liver function tests, and renal function every 3-6 months, but do not mention thyroid testing. 2
The 2016 British Association of Dermatologists guidelines similarly focus monitoring on FBC, liver function, and renal function (U&Es) every 1-2 weeks initially, then every 2-3 months, without thyroid assessment. 3
The 2009 AAD guidelines for psoriasis management list comprehensive monitoring parameters including CBC, LFTs, BUN, and creatinine, but thyroid function is not included. 4
Practical Monitoring Approach
Given the research evidence showing decreased TT4 with MTX use, consider baseline thyroid function testing and periodic monitoring in patients at higher risk for thyroid dysfunction:
Patients with pre-existing autoimmune conditions (RA, psoriasis, psoriatic arthritis) already have increased baseline risk of thyroid disease. 1
If unexplained fatigue, weight changes, or other thyroid-related symptoms develop during MTX therapy, check thyroid function tests (TSH, free T4, total T4). 1
The thyroid effect appears to be a class effect related to MTX's antifolate mechanism, similar to other metabolic impacts. 1
Important Caveats
This thyroid effect is not considered a major toxicity requiring routine surveillance in current practice, as evidenced by its absence from all major guidelines. 3, 2, 3, 4
The clinical significance of isolated TT4 reduction without TSH elevation remains unclear and may not require intervention in asymptomatic patients. 1
Standard MTX monitoring focuses on more serious toxicities: bone marrow suppression, hepatotoxicity, pulmonary toxicity, and renal impairment. 2, 3, 5
Folic acid supplementation (recommended for all MTX patients) may help mitigate some metabolic effects, though its specific impact on thyroid function is not established. 3